Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye-Jee Kim

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Cardiovascular Diabetology|May 22, 2022
Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort studySi Hyoung Kim, Yun Kyung Cho, Ye-Jee Kim, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2024
Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based studyJeongkuk Seo, Seonok Kim, Seung Wook Hong, et al.
Cancer Research and Treatment|July 24, 2025
Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver FunctionWon-Jung Jung, Eun-Jung Jo, Ye-Jee Kim, et al.
Journal for Immunotherapy of Cancer|September 15, 2021
Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational studySeongman Bae, Ye-Jee Kim, Min-Ju Kim, et al.
Journal of Gastroenterology and Hepatology|March 18, 2021
Risk factors for rebleeding in Crohn's disease patients with acute severe lower gastrointestinal bleeding: With special reference to the role of anti-tumor necrosis factor therapyDae Sung Kim, Jiyoung Yoon, Ye-Jee Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel DiseasesHyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, et al.
Clinical Therapeutics|August 15, 2025
Real-World Utilization Patterns of Immune Checkpoint Inhibitors Based on the National Health Insurance Service Data in KoreaEunji Kim, Yu-Seon Jung, Jongmin Lee, et al.
Heart (British Cardiac Society)|September 12, 2020
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosisSahmin Lee, Seung-Ah Lee, Bongkun Choi, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2019
Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDR<i>plus</i> assay: A prospective, multicenter, non-inferiority randomized trial in South KoreaKyung-Wook Jo, Mihye Kim, Ye-Jee Kim, et al.
Journal of Gastroenterology and Hepatology|December 15, 2018
Incidence and clinical impact of perianal disease in patients with ulcerative colitis: A nationwide population-based studyEun Mi Song, Ho-Su Lee, Ye-Jee Kim, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Cardiovascular Diabetology|May 22, 2022
Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort studySi Hyoung Kim, Yun Kyung Cho, Ye-Jee Kim, et al.
Alimentary Pharmacology & Therapeutics|June 12, 2024
Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based studyJeongkuk Seo, Seonok Kim, Seung Wook Hong, et al.
Cancer Research and Treatment|July 24, 2025
Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver FunctionWon-Jung Jung, Eun-Jung Jo, Ye-Jee Kim, et al.
Journal for Immunotherapy of Cancer|September 15, 2021
Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational studySeongman Bae, Ye-Jee Kim, Min-Ju Kim, et al.
Journal of Gastroenterology and Hepatology|March 18, 2021
Risk factors for rebleeding in Crohn's disease patients with acute severe lower gastrointestinal bleeding: With special reference to the role of anti-tumor necrosis factor therapyDae Sung Kim, Jiyoung Yoon, Ye-Jee Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel DiseasesHyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, et al.
Clinical Therapeutics|August 15, 2025
Real-World Utilization Patterns of Immune Checkpoint Inhibitors Based on the National Health Insurance Service Data in KoreaEunji Kim, Yu-Seon Jung, Jongmin Lee, et al.
Heart (British Cardiac Society)|September 12, 2020
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosisSahmin Lee, Seung-Ah Lee, Bongkun Choi, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2019
Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDR<i>plus</i> assay: A prospective, multicenter, non-inferiority randomized trial in South KoreaKyung-Wook Jo, Mihye Kim, Ye-Jee Kim, et al.
Journal of Gastroenterology and Hepatology|December 15, 2018
Incidence and clinical impact of perianal disease in patients with ulcerative colitis: A nationwide population-based studyEun Mi Song, Ho-Su Lee, Ye-Jee Kim, et al.
Pageof 16